CF-033 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

3,764 results for “CF-033”

Trials

View all 1885 →

IDEA-033 Open Label Study

491 participants · First posted Sep 6, 2006

IDEA-033 Three Months Dose Finding in OA Followed by IDEA-033 Three Months Extension in OA

704 participants · First posted Apr 21, 2006

Virtual Care in CF (VIRTUAL-CF) Study

100 participants · First posted Mar 3, 2017

Drugs

View all 1406 →

PG-033

CF-53

CF-1368

Organizations

View all 219 →

CF PHARMTECH

CF PHARMA LLC

United States

Rijnstate

Netherlands

News

View all 254 →

C-Further Launches First Pediatric Cancer Programs with $40M Budget, Partners with MiNK Therapeutics

Cystic Fibrosis Foundation Invests $15 Million in Recode Therapeutics for CF Gene Editing

Exelixis and Merck Launch Phase 3 LITESPARK-033 Trial Testing Novel Kidney Cancer Combination Therapy

Page 1 of 377